Poor
Not Aligned
Patient Risk:
Medium
Summary
The AI-generated statements are largely general/physiology-based about milk buffering aspirin effects and non-label risk-prevention advice, which are not supported by the provided prescribing information. The few label-matching items about aspirin being an NSAID and product indications/dosing are not sufficient to offset multiple unsupported or not label-grounded claims.
Category Scores
Accurate Statements
Aspirin is a nonsteroidal anti-inflammatory drug (NSAID).
Not explicitly provided in the label excerpts, but consistent with the product containing aspirin; however, no explicit label text was supplied in the prompt confirming this wording.
Unsupported Statements
Milk can buffer stomach contents and may reduce irritation from aspirin for some people.
No label support in the provided prescribing information regarding milk buffering or reducing aspirin irritation.
Milk does not remove aspirin’s potential to cause stomach bleeding.
Label excerpt discusses bleeding risk from the product and risk factors, but does not provide any milk-specific statement.
Milk does not remove aspirin’s potential to cause ulcers.
No milk-specific statement in the provided label excerpts.
The risk of gastrointestinal side effects from aspirin comes from the drug itself, not only from how it feels.
The label excerpts address bleeding risk and GI bleeding, but do not frame it in terms of milk reducing/affecting the mechanism described here.
Taking aspirin with food (or with milk) can be gentler than taking it on an empty stomach for many people.
Label excerpt states the product can be administered with or without food, but provides no milk-specific or 'gentler than empty stomach' claim.
“Gentler” is not the same as “safe,” especially for people with a history of ulcers, reflux complications, or bleeding.
The label excerpts provided do not mention reflux or 'ulcers/reflux complications' as described, nor any milk/food 'gentler' framing.
People should be extra cautious or avoid aspirin unless a clinician specifically recommends it if they have a history of stomach ulcers or GI bleeding.
The provided label excerpts do not include this as written guidance; only general bleeding risk is discussed.
People should be extra cautious or avoid aspirin unless a clinician specifically recommends it if they have bleeding disorders or are on blood thinners.
The label excerpt mentions increased risk for bleeding when combined with anticoagulants/antiplatelets, but does not support this blanket 'avoid unless clinician recommends' instruction.
People should be extra cautious or avoid aspirin unless a clinician specifically recommends it if they have uncontrolled high blood pressure.
No label excerpt provided regarding uncontrolled high blood pressure and aspirin avoidance.
People should be extra cautious or avoid aspirin unless a clinician specifically recommends it if they have certain allergies to NSAIDs.
The label excerpts include contraindications for NSAID allergy/hypersensitivity, but the AI advice is framed as 'extra cautious or avoid unless clinician specifically recommends,' which is not the contraindication language from the label.
Clinicians sometimes use stomach-protecting medications (for example, acid-suppressing therapy) to prevent aspirin-related stomach problems rather than relying on milk alone.
No such statement appears in the provided prescribing information.
Milk’s buffering can change how quickly stomach contents react.
No label support for milk altering drug effect timing via gastric buffering.
Milk does not meaningfully neutralize aspirin.
No label support for milk neutralization claims.
Milk does not reliably reduce aspirin’s blood-thinning effects.
No label support addressing milk reliability for aspirin antiplatelet effects.
Milk does not reliably reduce aspirin’s anti-inflammatory effects.
No label support addressing milk effect on aspirin anti-inflammatory effects.
If milk changes an aspirin dosing schedule (timing), that can affect symptom control.
No label support for milk affecting dosing timing and 'symptom control' (and 'symptom control' is not used in the provided label excerpts).
Contradictions
Important Omissions
Product-specific labeled indication context (reduce risk of stroke after TIA or completed ischemic stroke due to thrombosis) was not addressed, while many milk/food general statements were made.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Medium
While many statements are not directly contradictory, the response provides non-label milk/food-based guidance and avoidance advice not supported by the provided prescribing information; this could mislead users about managing GI bleeding/ulcer risk or drug effects.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Most claims about milk buffering and effects on aspirin GI bleeding/ulcer risk and antiplatelet/anti-inflammatory effects are not supported by the provided FDA label excerpts; several safety/avoidance recommendations are not label-grounded.
Suggested Improvement
Restrict statements to label-supported facts from the provided prescribing information (e.g., product indication; administration with or without food; contraindications such as NSAID allergy/asthma/rhinitis/nasal polyps and pediatric Reye risk; bleeding risk and increased bleeding with anticoagulants/antiplatelets; avoidance in severe renal failure). Remove milk-specific efficacy/safety claims unless the label explicitly addresses them.